Lista de obras -

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

artículo científico publicado en 1998

A hemodynamic study of pulmonary hypertension in sickle cell disease

artículo científico publicado en 2011

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica.

artículo científico publicado en 2016

Automatic quantification of right ventricular function with gated blood pool SPECT.

artículo científico publicado en 2004

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation

scientific article published on 30 July 2020

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease

article

Chronic thromboembolic pulmonary hypertension

scientific article published on 12 November 2015

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

scientific article published on 16 July 2020

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

artículo científico publicado en 2018

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

artículo científico publicado en 2017

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease

scientific article published on 04 December 2019

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

scientific article published on 01 February 1996

Criteria for diagnosis of exercise pulmonary hypertension.

artículo científico publicado en 2015

Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2006

Deep venous thrombosis and pulmonary embolism

artículo científico publicado en 2002

Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance

artículo científico publicado en 2005

Diagnosis and management of subsegmental pulmonary embolism.

artículo científico publicado en 2006

Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study.

artículo científico publicado en 2002

Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome study.

artículo científico publicado en 2006

Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group

artículo científico publicado en 1998

Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism.

artículo científico publicado en 2012

Effect of age on the performance of a diagnostic strategy based on clinical probability, spiral computed tomography and venous compression ultrasonography: the ESSEP study.

artículo científico publicado en 2005

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

scientific article published on 18 June 2020

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

scientific article published on 20 April 2011

Estimating right ventricular stroke work and the pulsatile work fraction in pulmonary hypertension

artículo científico publicado en 2013

Factors predicting outcome after pulmonary endarterectomy.

artículo científico publicado en 2018

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2019

Genetic counselling in a national referral centre for pulmonary hypertension.

artículo científico publicado en 2015

High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism

artículo científico publicado en 1999

Hypertension pulmonaire postembolique

artículo científico publicado en 2007

Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues

artículo científico publicado en 2017

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre ⬇️

artículo científico publicado el 1 de diciembre de 2009

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

artículo científico publicado en 1998

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

artículo científico publicado en 1995

Long term imatinib treatment in pulmonary arterial hypertension.

artículo científico publicado en 2006

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

artículo científico publicado en 2002

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

artículo científico publicado en 2016

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

artículo científico publicado en 2009

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2005

Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism

artículo científico publicado en 1997

Medical literature and vena cava filters: so far so weak

artículo científico publicado en 2002

Medical literature, vena cava filters and evidence of efficacy. A descriptive review.

artículo científico publicado en 2013

Occult alveolar haemorrhage in pulmonary veno-occlusive disease.

artículo científico publicado en 2006

Pathobiology of pulmonary hypertension. The role of platelets and thrombosis

artículo científico publicado en 2001

Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension

scientific article published on 27 April 2019

Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism

artículo científico publicado en 2014

Primary pulmonary hypertension and fenfluramine use

artículo científico publicado en 1993

Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study

artículo científico publicado en 2009

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

artículo científico publicado en 2003

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

scientific article published on 01 April 1997

Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial

artículo científico publicado en 2008

Pulmonary Hypertension Complicating Fibrosing Mediastinitis

artículo científico publicado en 2015

Pulmonary arterial hypertension and sickle cell disease

artículo científico publicado en 2012

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

artículo científico publicado en 2007

Pulmonary arterial hypertension in patients treated with interferon.

artículo científico publicado en 2014

Pulmonary hypertension and obesity

artículo científico publicado en 2002

Pulmonary hypertension complicating systemic diseases other than connective tissue diseases

artículo científico publicado en 2003

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension

artículo científico publicado en 1994

Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different

artículo científico publicado en 2012

Pulmonary thromboendarterectomy with video-angioscopy and circulatory arrest: an alternative to cardiopulmonary transplantation and post-embolism pulmonary artery hypertension

artículo científico publicado en 1998

Pulmonary veno-occlusive disease

artículo científico publicado en 2016

RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

artículo científico publicado en 2018

Rapid Contour-based Segmentation for 18F-FDG PET Imaging of Lung Tumors by Using ITK-SNAP: Comparison to Expert-based Segmentation.

artículo científico publicado en 2018

Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism

artículo científico publicado en 1995

Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210G/A mutations

artículo científico publicado en 1998

Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension

artículo científico publicado en 2015

Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention

artículo científico publicado en 2017

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

artículo científico publicado en 2017

Risk factors for pulmonary arterial hypertension.

artículo científico publicado en 2001

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial

artículo científico publicado en 2018

Safety of therapeutic doses of tinzaparin during pregnancy

artículo científico publicado en 2015

Screening for pulmonary arterial hypertension in adults carrying a <i>BMPR2</i> mutation

scientific article published on 30 December 2020

Severe Pulmonary Hypertension in Histiocytosis X

artículo científico publicado en 2000

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study

artículo científico publicado en 1999

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

artículo científico publicado en 1999

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial

artículo científico

Splenectomy and chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2005

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

artículo científico publicado en 2010

The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.

artículo científico publicado en 2017

The association between resting and mild-to-moderate exercise pulmonary artery pressure

artículo científico publicado en 2011

The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension.

artículo científico publicado en 2014

Thrombotic risk factors in pulmonary hypertension

artículo científico publicado en 2000

Treatment of severe venous thrombo-embolism with intravenous Hirudin (HBW 023): an open pilot study

scientific article published on 01 September 1993

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension

artículo científico publicado en 2015

Venous thromboembolism and COVID-19

artículo científico publicado en 2020

Ventilation/perfusion lung scan in pulmonary veno-occlusive disease

artículo científico publicado en 2011

Vitamin K Metabolism in a Patient Resistant to Vitamin K Antagonists ⬇️

artículo científico publicado el 1 de julio de 1997

[Antithrombotic therapy for venous thromboembolism - report of the 7th Conference of The American College of Chest Physicians]

artículo científico publicado en 2005

[Chronic pulmonary heart disease: therapeutic indications]

scientific article published on 01 November 1995

[Helical computed tomography in suspected pulmonary embolism]

artículo científico publicado en 2003

[Post-embolic pulmonary arterial hypertension: therapeutic indications]

scientific article published on 01 December 1995

[Pulmonary arterial hypertension due to tumor emboli]

artículo científico publicado en 2007

[Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]

artículo científico publicado en 1994

[Pulmonary complications in adult sickle cell disease].

artículo científico publicado en 2011

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]

artículo científico publicado en 2019

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]

scientific article published on 22 February 2019

[Surgical treatment of chronic thromboembolic pulmonary hypertension]

artículo científico publicado en 2005

[Surgical treatment of post-embolism pulmonary hypertension]

artículo científico publicado en 2004

[What are the special features of the treatment of venous thombo-embolic disease in the course of pregnancy and post-partum?]

artículo científico publicado en 2019

[When and how to investigate chronic thrombo-embolic pulmonary hypertension after a pulmonary embolism?]

scientific article published on 11 October 2019

Lista de obras de

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

A hemodynamic study of pulmonary hypertension in sickle cell disease

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica.

Automatic quantification of right ventricular function with gated blood pool SPECT.

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease

Chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

Criteria for diagnosis of exercise pulmonary hypertension.

Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension

Deep venous thrombosis and pulmonary embolism

Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance

Diagnosis and management of subsegmental pulmonary embolism.

Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study.

Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome study.

Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group

Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism.

Effect of age on the performance of a diagnostic strategy based on clinical probability, spiral computed tomography and venous compression ultrasonography: the ESSEP study.

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

Estimating right ventricular stroke work and the pulsatile work fraction in pulmonary hypertension

Factors predicting outcome after pulmonary endarterectomy.

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Genetic counselling in a national referral centre for pulmonary hypertension.

High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism

Hypertension pulmonaire postembolique

Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre ⬇️

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Long term imatinib treatment in pulmonary arterial hypertension.

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism

Medical literature and vena cava filters: so far so weak

Medical literature, vena cava filters and evidence of efficacy. A descriptive review.

Occult alveolar haemorrhage in pulmonary veno-occlusive disease.

Pathobiology of pulmonary hypertension. The role of platelets and thrombosis

Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension

Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism

Primary pulmonary hypertension and fenfluramine use

Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial

Pulmonary Hypertension Complicating Fibrosing Mediastinitis

Pulmonary arterial hypertension and sickle cell disease

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

Pulmonary arterial hypertension in patients treated with interferon.

Pulmonary hypertension and obesity

Pulmonary hypertension complicating systemic diseases other than connective tissue diseases

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension

Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different

Pulmonary thromboendarterectomy with video-angioscopy and circulatory arrest: an alternative to cardiopulmonary transplantation and post-embolism pulmonary artery hypertension

Pulmonary veno-occlusive disease

RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

Rapid Contour-based Segmentation for 18F-FDG PET Imaging of Lung Tumors by Using ITK-SNAP: Comparison to Expert-based Segmentation.

Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism

Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210G/A mutations

Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension

Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

Risk factors for pulmonary arterial hypertension.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial

Safety of therapeutic doses of tinzaparin during pregnancy

Screening for pulmonary arterial hypertension in adults carrying a <i>BMPR2</i> mutation

Severe Pulmonary Hypertension in Histiocytosis X

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial

Splenectomy and chronic thromboembolic pulmonary hypertension.

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.